Publications by authors named "Patrick A Howson"

Claim this Profile
B
Beneficial Effects of Trehalose on Striatal Dopaminergic Deficits in Rodent and Primate Models of Synucleinopathy in Parkinson's Disease.
Patrick A Howson, Tom H Johnston, Paula Ravenscroft, Michael P Hill, Jin Su

J Pharmacol Exp Ther· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic/Pharmacodynamic Correlation Analysis of Amantadine for Levodopa-Induced Dyskinesia.
Elizabeth F Brigham, Tom H Johnston, Carl Brown, Jonathon D S Holt, Susan H Fox, Patrick A Howson

J Pharmacol Exp Ther· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-steric-zipper models for pathogenic α-synuclein conformers.
Brock Schuman, Amy Won, Koroboshka Brand-Arzamendi, James B Koprich, Xiao-Yan Wen, Patrick A Howson

APL Bioeng· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.
Tom H Johnston, Eboo Versi, Patrick A Howson, Paula Ravenscroft, Susan H Fox

Neuropharmacology· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The link between mitochondrial complex I and brain-derived neurotrophic factor in SH-SY5Y cells--The potential of JNX1001 as a therapeutic agent.
Helena K Kim, Karina M Mendonça, Patrick A Howson, Jonathan M Brotchie, Ana C Andreazza

Eur J Pharmacol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabotropic glutamate receptor mGlu2 is resistant to homologous agonist-induced desensitization but undergoes protein kinase C-mediated heterologous desensitization.
Siân M Lennon, Guadalupe Rivero, Annelise Matharu, Patrick A Howson, David E Jane

Eur J Pharmacol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons and by MPTP in a mouse model of Parkinson's disease.
Naomi P Visanji, Antonia Orsi, Tom H Johnston, Patrick A Howson, Kimberly Dixon

FASEB J· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenylglycine derivatives as antagonists of group III metabotropic glutamate receptors expressed on neonatal rat primary afferent terminals.
Jacqueline C Miller, Patrick A Howson, Stuart J Conway, Richard V Williams, Barry P Clark

Br J Pharmacol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Actions of LY341495 on metabotropic glutamate receptor-mediated responses in the neonatal rat spinal cord.
Patrick A Howson, David E Jane

Br J Pharmacol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis